Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma. [electronic resource] by
- Cardona, A F
- Rojas, L
- Wills, B
- Ruiz-Patiño, A
- Abril, L
- Hakim, F
- Jiménez, E
- Useche, N
- Bermúdez, S
- Mejía, J A
- Ramón, J F
- Carranza, H
- Vargas, C
- Otero, J
- Archila, P
- Rodríguez, J
- Rodríguez, J
- Behaine, J
- González, D
- Jacobo, J
- Cifuentes, H
- Feo, O
- Penagos, P
- Pineda, D
- Ricaurte, L
- Pino, L E
- Vargas, C
- Marquez, J C
- Mantilla, M I
- Ortiz, L D
- Balaña, C
- Rosell, R
- Zatarain-Barrón, Z L
- Arrieta, O
Producer: 20191226
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 21
Availability: No items available.
|